| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-06 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.69 | 1e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.69 | 3e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |